Controlled Release Floating Matrix Tablet of Captopril
The present study was done to prepare a gastroretentive floating tablet of captopril (CAP) which is an angiotensin converting enzyme inhibitor (ACE-inhibitor) used in the treatment of hypertension and heart failure. CAP is mainly absorbed from the proximal intestine and to a lesser extent from the s...
Saved in:
Main Authors: | Haithem N. Abed (Author), Alaa A. Abdulrasool (Author), Mowafaq M. Ghareeb (Author) |
---|---|
Format: | Book |
Published: |
College of Pharmacy University of Baghdad,
2017-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Controlled Release Floating Matrix Tablet of Captopril
by: Haithem N. Abed, et al.
Published: (2017) -
Sustained Release of Captopril Tablet with Floating System Using a Cross-Linked Matrix of Alginate
by: Dhadhang Wahyu Kurniawan, et al.
Published: (2019) -
Formulation, evaluation and optimization of sustained release matrix tablets of captopril
by: V Pinank Pandya, et al.
Published: (2012) -
Formulation, release characteristics, and bioavailability study of gastroretentive floating matrix tablet and floating raft system of Mebeverine HCl
by: El Nabarawi MA, et al.
Published: (2017) -
Combination of FDM 3D Printing and Compressed Tablet for Preparation of Baclofen as Gastro-Floating Drug Delivery System (Conference Paper )#
by: Nuha Mohammed Abdulkhaleq, et al.
Published: (2023)